Zanubrutinib is active for the treatment of relapsed primary vitreoretinal lymphoma

Amina Lateef Chaudhry; Patricia Chévez-Barrios; Paolo Strati

doi:10.1080/10428194.2025.2539227

Zanubrutinib is active for the treatment of relapsed primary vitreoretinal lymphoma

Amina Lateef Chaudhry, Patricia Chévez-Barrios, Paolo Strati

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	2316-2319
Number of pages	4
Journal	Leukemia and Lymphoma
Volume	66
Issue number	12
DOIs	https://doi.org/10.1080/10428194.2025.2539227
State	Published - 2025

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1080/10428194.2025.2539227

Cite this

@article{f07b9c4a802249b1b703b02f7ecb5aa9,

title = "Zanubrutinib is active for the treatment of relapsed primary vitreoretinal lymphoma",

author = "Chaudhry, \{Amina Lateef\} and Patricia Ch{\'e}vez-Barrios and Paolo Strati",

year = "2025",

doi = "10.1080/10428194.2025.2539227",

language = "English (US)",

volume = "66",

pages = "2316--2319",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Taylor and Francis Ltd.",

number = "12",

}

TY - JOUR

T1 - Zanubrutinib is active for the treatment of relapsed primary vitreoretinal lymphoma

AU - Chaudhry, Amina Lateef

AU - Chévez-Barrios, Patricia

AU - Strati, Paolo

PY - 2025

Y1 - 2025

UR - https://www.scopus.com/pages/publications/105012105462

UR - https://www.scopus.com/inward/citedby.url?scp=105012105462&partnerID=8YFLogxK

U2 - 10.1080/10428194.2025.2539227

DO - 10.1080/10428194.2025.2539227

M3 - Letter

C2 - 41103143

AN - SCOPUS:105012105462

SN - 1042-8194

VL - 66

SP - 2316

EP - 2319

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 12

ER -

Zanubrutinib is active for the treatment of relapsed primary vitreoretinal lymphoma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this